Hims & Hers Health is trading 8.3% up today at €30.70, rebounding from recent weakness despite a lack of company-specific headlines.
- The move aligns with a broader rally in the healthcare sector, where medical device and clinical research names are gaining on upbeat earnings and guidance.
- In the absence of fresh company news, today’s advance appears driven by a sector-wide bid and improved risk appetite for healthcare stocks.